T. Rowe Price Health Care ETFTMED
Type
ETF
Peer group
US equity: Healthcare
Net assets
$20.3M
Expense ratio
0.44%
1-year return
—
3 years, a year
—
5 years, a year
—
Holdings
109
What it aims to do.
The fund seeks long-term capital appreciation.
Top 10 holdings.
| Holding | % of fund |
|---|---|
| LLY Eli Lilly & Co | 14.48% |
| UNH Unitedhealth Group Inc | 6.54% |
| TMO Thermo Fisher Scientific Inc | 4.59% |
| GILD Gilead Sciences Inc | 4.14% |
| ABT Abbott Laboratories | 3.91% |
| DHR Danaher Corp | 2.73% |
| MDT Medtronic Plc | 2.24% |
| ALNY Alnylam Pharmaceuticals Inc | 2.06% |
| SYK Stryker Corp | 2.00% |
| DYN Dyne Therapeutics Inc | 1.88% |
More on TMED.
- TMED overview
- TMED holdings
- TMED risk
- TMED costs
- TMED money in and out
- TMED share classes
- Compare TMED with other funds
Returns after fees, from the fund's SEC filings up to Mar 2026. Past returns are not a promise. Not financial advice.